Catherine R Lesko1, Stephen R Cole1, William C Miller2, Daniel Westreich1, Joseph J Eron3, Adaora A Adimora2, Richard D Moore4, W Christopher Mathews5, Jeffrey N Martin6, Daniel R Drozd7, Mari M Kitahata7, Jessie K Edwards1, Michael J Mugavero8. 1. Department of Epidemiology, University of North Carolina. 2. Department of Epidemiology, University of North Carolina Department of Medicine, Division of Infectious Diseases, University of North Carolina, Chapel Hill. 3. Department of Medicine, Division of Infectious Diseases, University of North Carolina, Chapel Hill. 4. Johns Hopkins University, Baltimore, Maryland. 5. University of California San Diego, San Diego. 6. University of California San Francisco, San Francisco, California. 7. School of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle. 8. Department of Medicine, Division of Infectious Diseases, University of Alabama, Birmingham.
Abstract
BACKGROUND: Ensuring equal access to antiretroviral therapy (henceforth therapy) should alleviate disparities in health outcomes among persons infected with human immunodeficiency virus (HIV). However, evidence supporting the persistence of disparities in survival following therapy initiation is mixed. METHODS: Patients initiating therapy in eight academic medical centers in the Centers for AIDS Research Network of Integrated Clinical Systems between 1 January 1998 and 30 December 2011. Patients (n = 10 017) were followed from therapy initiation until death from any cause, administrative censoring at 10 years after therapy initiation or the end of follow-up on 31 December 2011. The 10-year risk of all-cause mortality was calculated from standardized Kaplan-Meier survival curves. RESULTS: Patients were followed for a median of 4.7 years (interquartile range: 2.2, 8.2). During 51 121 person-years of follow-up, 1224 of the 10 017 patients died. The overall 10-year mortality risk was 20.2% (95% confidence interval [CI], 19.2%, 21.3%). Black men and women experienced standardized 10-year all-cause mortality risks that were 7.2% (95% CI, 4.3%, 10.1%) and 7.9% (95% CI, 3.9%, 12.0%) larger (absolute difference) than white men. White women, Hispanic men, and Hispanic women all had lower 10-year mortality than white men. CONCLUSIONS: These data serve as a call to action to identify modifiable mechanisms leading to these observed mortality disparities among HIV-infected black patients. Effective interventions are needed to ensure that the goal of the National HIV/AIDS Strategy to overcome health disparities becomes a reality.
BACKGROUND: Ensuring equal access to antiretroviral therapy (henceforth therapy) should alleviate disparities in health outcomes among persons infected with human immunodeficiency virus (HIV). However, evidence supporting the persistence of disparities in survival following therapy initiation is mixed. METHODS:Patients initiating therapy in eight academic medical centers in the Centers for AIDS Research Network of Integrated Clinical Systems between 1 January 1998 and 30 December 2011. Patients (n = 10 017) were followed from therapy initiation until death from any cause, administrative censoring at 10 years after therapy initiation or the end of follow-up on 31 December 2011. The 10-year risk of all-cause mortality was calculated from standardized Kaplan-Meier survival curves. RESULTS:Patients were followed for a median of 4.7 years (interquartile range: 2.2, 8.2). During 51 121 person-years of follow-up, 1224 of the 10 017 patients died. The overall 10-year mortality risk was 20.2% (95% confidence interval [CI], 19.2%, 21.3%). Black men and women experienced standardized 10-year all-cause mortality risks that were 7.2% (95% CI, 4.3%, 10.1%) and 7.9% (95% CI, 3.9%, 12.0%) larger (absolute difference) than white men. White women, Hispanic men, and Hispanic women all had lower 10-year mortality than white men. CONCLUSIONS: These data serve as a call to action to identify modifiable mechanisms leading to these observed mortality disparities among HIV-infected blackpatients. Effective interventions are needed to ensure that the goal of the National HIV/AIDS Strategy to overcome health disparities becomes a reality.
Authors: R Weber; M Ruppik; M Rickenbach; A Spoerri; H Furrer; M Battegay; M Cavassini; A Calmy; E Bernasconi; P Schmid; M Flepp; J Kowalska; B Ledergerber Journal: HIV Med Date: 2012-09-24 Impact factor: 3.180
Authors: Victoria Hernando; Paz Sobrino-Vegas; M Carmen Burriel; Juan Berenguer; Gemma Navarro; Ignacio Santos; Jesús Reparaz; M Angeles Martínez; Antonio Antela; Félix Gutiérrez; Julia del Amo Journal: AIDS Date: 2012-09-10 Impact factor: 4.177
Authors: Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne Journal: Lancet Date: 2002-07-13 Impact factor: 79.321
Authors: H Irene Hall; Emma L Frazier; Philip Rhodes; David R Holtgrave; Carolyn Furlow-Parmley; Tian Tang; Kristen Mahle Gray; Stacy M Cohen; Jonathan Mermin; Jacek Skarbinski Journal: JAMA Intern Med Date: 2013-07-22 Impact factor: 21.873
Authors: Kriti M Jain; Cathy Maulsby; Suzanne Kinsky; Vignetta Charles; David R Holtgrave Journal: Am J Public Health Date: 2016-03 Impact factor: 9.308
Authors: Linda Beer; Heather Bradley; Christine L Mattson; Christopher H Johnson; Brooke Hoots; Roy L Shouse Journal: J Acquir Immune Defic Syndr Date: 2016-12-01 Impact factor: 3.731
Authors: Whitney S Rice; Kristi L Stringer; Maira Sohail; Kaylee B Crockett; Ghislaine C Atkins; Kachina Kudroff; D Scott Batey; Joshua Hicks; Janet M Turan; Michael J Mugavero; Bulent Turan Journal: AIDS Behav Date: 2019-11
Authors: Melissa Marzán-Rodríguez; Diego E Zavala Segarra; Juan Carlas Orengo Valverde; Nelson Varas-Díaz; Sandra Miranda De León; Eliseo Acevedo-Díaz Journal: Rev Puertoriq Med Salud Publica Date: 2018
Authors: Joëlla W Adams; Kendall J Bryant; E Jennifer Edelman; David A Fiellin; Julie R Gaither; Adam J Gordon; Kirsha S Gordon; Kevin L Kraemer; Matthew J Mimiaga; Don Operario; Janet P Tate; Jacob J van den Berg; Amy C Justice; Brandon D L Marshall Journal: AIDS Behav Date: 2018-04
Authors: Lauren Lipira; Emily C Williams; David Huh; Christopher G Kemp; Paul E Nevin; Preston Greene; Joseph M Unger; Patrick Heagerty; Audrey L French; Susan E Cohn; Janet M Turan; Michael J Mugavero; Jane M Simoni; Michele P Andrasik; Deepa Rao Journal: AIDS Behav Date: 2019-08